survey biopharma cfos/budget manag assess biopharma end market
total tool sale demand survey indic biopharma end market
revenu grow addit china growth remain solid
base survey data closer review revenu mix
appear best posit rel current street expect
link full note
last thursday deliv good result reiter ep guidanc ex
celgen also issu celg pro-forma revenu net incom project
first time project well last publish pro-forma model
lower revenu net incom discuss chang
model stock look cheap signific uncertainti
link full note
pleas see addendum report import disclosur
set bode continu momentum front data
set combin intra-quart check support view
street ww tavr cc growth estim highli achiev ew remain
top pick see upsid number expect posit
low risk data drive out-performance ww tavr unit anticip result
least support recent stock momentum reiter outperform
link full note
new jec balanc gov infrastructur servic firm mix
shed legaci biz newco offer mid-teen averag ep growth
trade histor averag respect new peer group pt
link full note
adjust forward sale estim base recent
launch quarter meaning metric potenti forward growth
link full note
met axon recent discuss detail new gene therapi
program well futur updat pipelin program first patient
dose interim data expect
neurolog gene therapi product pipelin key manag addit
expect signific clinic progress cours
link full note
preorder order abl play vip demo schedul
last weekend unfortun time game mar sever
technic problem plagu mani player ea seem get
way come aaa non-sport titl releas maintain market perform
link full note
dispatch kassel sma investor day highlight improv solar backdrop
attend sma capit market day last week germani sma
challeng due weak solar macro self inflict challeng commentari
around broader solar outlook posit product refresh segment
resi/c util drive growth especi util storag integr comment
also bullish similar outlook sedg/enph
link full note
mark continu progress eric recoveri improv margin
revenu growth commentari tone posit progress toward long-
term oper target network post second straight quarter solid growth
margin ran market continu improv maintain market perform
given share trade pf ep ev/rev
link full note
built scalabl gov servic presenc sale emerg
downturn oil-fac biz initi market perform given below-consensu
outlook near term overhang potenti catalyst guidanc
logcap recompet award track complet ichthi pt impli
link full note
beat provid increas evid aircraft margin enter long anticip
period extend growth thu see oper upsid estim
potenti redeploy pluse sell tev/ebitda
link full note
oliv chen host ceo chri rondeau cfo dorvin live discuss
evolv competit set top driver comp momentum matur comp
waterfal key un-amazon- featur also manag excit launch
new app could revolution gym experi provid valuabl
link full note
adjust forward sale estim base
net product revenu guidanc provid earli januari
matur dmd portfolio view announc sale guidanc like
achiev includ market model gt-aadc bla/maa file
link full note
world feb orlando sangamo present data patient
enrol low- mid- high-dos cohort on-going mpsii vivo gene
edit program expect result increment posit anticip
data conclus defin program clinic promis believ
meaning long-term data like come later year
link full note
see navi shipbuild stable-to-grow segment risk
upcom plan congress could add ship budget improv
current expect shipbuild also anticip signific contract
next sever month surpris new surfac program navi intend
pursu pay major program
link full note
what miss financi hous
like washington longer shutdown event
monday account standard board hold hear current
expect credit loss method loan loss reserv expect materi chang
also two-day meet feder reserv chairman jerom powel
hold press confer pm wednesday
link full note
jan feb prepar today fasb forum cecl loan loss standard
account standard board hold forum today current expect
credit loss approach loan loss reserv worri standard pro-
cyclic expect fasb make materi chang delay standard
might still tabl howev addit regulatori action address bank
worri stress test cecl
link full note
state legislatur get work accord studi
health care bill drop far deal pbm good news
industri deal gag claus toothless transpar measur
consid allow state move medicaid block grant littl known
detail babi shark still chart
link full note
c-band propos like overcom opposit win fcc approv
see chanc fcc approv realloc via privat auction
mhz spectrum terrestri use leadership fcc
top prioriti resist influenti group media co public interest group
remain risk realloc would good verizon
could repres headwind
link full note
rise privaci nois around facebook googl
given recent news flow think matter upcom rule facebook
europ rule germani ireland under-appreci concern facebook
googl
 loom ftc rule facebook fine modest new limit break-up
unlik
tim cook may creat new risk data broker liveramp
link full note
high-level us-china talk potenti unilater execut action huawei possibl
venezuela sanction duel drug price hear start tax file season fed press
confer rusal remov treasuri sanction job report day
day divid govern first full week open
link full note
jan drug price hear
postpon presid trump state union address focu
week turn health polici hear congress
senat financ hous oversight committe schedul hold
hear tomorrow discuss drug price like creat headlin risk
link full note
import disclosur inform relat cowen washington research group
